Advertisement
Canada markets open in 19 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.02%)
     
  • CRUDE OIL

    84.19
    +0.62 (+0.74%)
     
  • Bitcoin CAD

    87,441.34
    +1,381.34 (+1.61%)
     
  • CMC Crypto 200

    1,383.29
    -13.24 (-0.95%)
     
  • GOLD FUTURES

    2,358.80
    +16.30 (+0.70%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     
  • NASDAQ futures

    17,744.00
    +176.50 (+1.00%)
     
  • VOLATILITY

    15.50
    +0.13 (+0.84%)
     
  • FTSE

    8,119.32
    +40.46 (+0.50%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

Dupixent May Be Strong Growth Driver for Sanofi in the Future

Regeneron (REGN) and Sanofi’s (SNY) Dupixent has seen stronger total prescription (or TRx) performance since its launch than Cosentyx, the dermatology biologic drug by Novartis (NVS).